An Epigenetic Nanoagonist Facilitates T Cell Priming, Recruitment, and Reinvigoration in Tumors Resistant to PD-L1 Therapy

Journal:

Advanced Materials

Published:

2025-08-29

DOI:

10.1002/adma.202502800

Affiliations:

9

Authors:

15

Go to article

Institutions	Authors	Share
The First Affiliated Hospital of Xi'an Jiaotong University, XJTU, China	7.000000	0.47
Xi'an Jiaotong University Health Science Center, China	4.000000	0.27
Xinjiang Medical University (XJMU), China	1.000000	0.07
State Key Laboratory of Green Hydrogen Electricity, XJTU, China	1.000000	0.07
Xi'an Jiaotong University (XJTU), China	1.000000	0.07
Shaanxi Normal University (SNNU), China	1.000000	0.07

Interested in Oncology and Carcinogenesis?